Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Neutral

Debt to Equity Rating

Neutral

Price to Earnings Rating

Sell

Analyst Rating

Buy

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Buy

Wall Street Data Solutions Rating

Neutral

B

Supernus Pharmaceuticals, Inc. (SUPN)

Pharmaceutical Preparations

https://www.supernus.com

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The Company's diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

9715 KEY WEST AVENUE
ROCKVILLE, MD

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/01/2012

Market Cap

1,904,442,624

Shares Outstanding

54,630,000

Weighted SO

54,632,847

Total Employees

N/A

Upcoming Earnings

08/13/2024

Similar Tickers

PBH --.--%

EVO --.--%

COLL --.--%

DCPH --.--%

EGRX --.--%

ANIP --.--%

PAHC --.--%

PCRX --.--%

RDY --.--%

Beta

0.9070

Last Div

0.0000

Range

21.99-35.44

Chg

0.3100

Avg Vol

616090

Mkt Cap

1904442624

Exch

NASDAQ

Country

US

Phone

301 838 2500

DCF Diff

-63.8166

DCF

98.5666

Div Yield

0.0000

P/S

3.0221

EV Multiple

14.8560

P/FV

1.9845

Div Yield %

0.0000

P/E

362.6774

PEG

28.9881

Payout

0.0000

Current Ratio

1.9148

Quick Ratio

1.6939

Cash Ratio

0.1688

DSO

88.3268

DIO

182.1312

Op Cycle

270.4581

DPO

12.3674

CCC

258.0906

Gross Margin

0.7833

Op Margin

0.0652

Pretax Margin

0.0594

Net Margin

0.0083

Eff Tax Rate

0.8600

ROA

0.0040

ROE

0.0056

ROCE

0.0408

NI/EBT

0.1400

EBT/EBIT

0.9107

EBIT/Rev

0.0652

Debt Ratio

0.0304

D/E

0.0418

LT Debt/Cap

0.0307

Total Debt/Cap

0.0401

Int Coverage

-8.5079

CF/Debt

3.8737

Equity Multi

1.3743

Rec Turnover

4.1324

Pay Turnover

29.5130

Inv Turnover

2.0040

FA Turnover

15.7383

Asset Turnover

0.4789

OCF/Share

2.8167

FCF/Share

2.8089

Cash/Share

6.3149

OCF/Sales

0.2457

FCF/OCF

0.9972

CF Coverage

3.8737

ST Coverage

15.9928

CapEx Coverage

363.5164

Div&CapEx Cov

363.5164

P/BV

1.9845

P/B

1.9845

P/S

3.0221

P/E

362.6774

P/FCF

12.3319

P/OCF

12.2697

P/CF

12.2697

PEG

28.9881

P/S

3.0221

EV Multiple

14.8560

P/FV

1.9845

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Nov 07, 16:30 Supernus to Participate in the Jefferies London Healthcare Conference

Revenue Product Segmentation